O
Ovid Therapeutics Inc (OVID)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$2.40
-0.14 (-5.51%)
Market Cap: $479.38M
Last updated: Nov 17, 2026 at 11:06 AM ET
Ovid Therapeutics Inc (OVID) Valuation Multiples
Ovid Therapeutics (OVID) trades at 335.8x sales and 2.5x book value. Its P/B of 2.5x is above its 5-year median of 1.3x. Its forward P/E is 1.8x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 1.8x |
| Price to sales | 335.8x |
| Price to book | 2.5x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/B is 47.1% above 1.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 2.5x | 1.3x | 1.7x |
Valuation History
Over the 5 of the 9 year ends shown that have a P/S, its P/S ranged from 11.2x in 2020 to 580.0x in 2023.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $1.63 | N/A | 16.2x | 1.0x |
| 2024 | $0.93 | N/A | 117.0x | 1.0x |
| 2023 | $3.22 | N/A | 580.0x | 2.6x |
| 2022 | $1.86 | N/A | 87.1x | 1.0x |
| 2021 | $3.21 | 1.6x | N/A | 1.2x |
| 2020 | $2.31 | N/A | 11.2x | 3.4x |
| 2019 | $4.15 | N/A | N/A | 2.9x |
| 2018 | $2.42 | N/A | N/A | 1.5x |
| 2017 | $9.87 | N/A | N/A | 2.9x |
Frequently Asked Questions About OVID
What is OVID's forward P/E ratio?
Ovid Therapeutics has a forward P/E ratio of 1.8x.
What is OVID's price to sales ratio?
Ovid Therapeutics has a price to sales ratio of 335.8x.
OVID pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors